東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

mRNA vaccines

Yu, Dong.

Linked to FindBook

Google Book

Amazon

博客來

mRNA vaccines

Record Type:	Electronic resources : Monograph/item
Title/Author:	mRNA vaccines/ edited by Dong Yu, Benjamin Petsch.
other author:	Yu, Dong.
Published:	Cham :Springer International Publishing : : 2022.,
Description:	xi, 205 p. :ill. (chiefly color), digital ;24 cm.
[NT 15003449]:	Preface -- mRNA-based vaccines and mode of action -- Self-Amplifying mRNA-Based Vaccine Technology and its Mode of Action -- Formulation and Delivery Technologies for mRNA Vaccines -- Messenger RNA-based vaccines against infectious diseases -- Emerge gate for Therapeutics applications of mRNA based drug -- Clinical Development of mRNA Vaccines: Challenges and Opportunities -- Regulatory Considerations on the Development of mRNA Vaccines.
Contained By:	Springer Nature eBook
Subject:	mRNA vaccines. -
Online resource:	https://doi.org/10.1007/978-3-031-18070-5
ISBN:	9783031180705

mRNA vaccines
mRNA vaccines[electronic resource] /edited by Dong Yu, Benjamin Petsch. - Cham :Springer International Publishing :2022. - xi, 205 p. :ill. (chiefly color), digital ;24 cm. - Current topics in microbiology and immunology,v. 4372196-9965 ;. - Current topics in microbiology and immunology ;v. 437..

Preface -- mRNA-based vaccines and mode of action -- Self-Amplifying mRNA-Based Vaccine Technology and its Mode of Action -- Formulation and Delivery Technologies for mRNA Vaccines -- Messenger RNA-based vaccines against infectious diseases -- Emerge gate for Therapeutics applications of mRNA based drug -- Clinical Development of mRNA Vaccines: Challenges and Opportunities -- Regulatory Considerations on the Development of mRNA Vaccines.

The formulation and the technological advancements in RNA biology, chemistry, stability, and encapsulated delivery systems that have enabled the development of fully synthetic mRNA vaccines are discussed in this volume. The applications of the mRNA technology is covered, focusing on infectious diseases but also touching on other indications, such as immunotherapies and molecular therapies. Potent and long-lasting immune responses observed in animal models, encouraging data from early human clinical studies, together with the success of two mRNA-based COVID-19 vaccines support the use of mRNA-based vaccination as an attractive alternative to conventional vaccine approaches. Consequently, the development progress of the technology, particularly on production, capabilities, and clinical development is reviewed. Topics on safety, regulatory issues, and possible challenges to the mRNA vaccination approach round off this book. Thanks to their high potency, the prospect for generic, low-cost manufacturing processes, and entirely synthetic nature, the future for mRNA vaccines is highly promising. Importantly, mRNA vaccines have the potential to minimize the time between pathogen identification and vaccine release with a huge impact on public health. As the mRNA-based vaccination technology has been progressing rapidly, the book is intended to be an end-to-end review series, covering everything from basic RNA biology and preclinical studies to the manufacturing strategy, clinical development and regulatory approval. It provides established RNA researchers and developers with updates on the latest advancements in the field and allows for a quick but comprehensive overview of this transformative technology, its application, and future potential.

ISBN: 9783031180705

Standard No.: 10.1007/978-3-031-18070-5doiSubjects--Topical Terms:

3605295
mRNA vaccines.

LC Class. No.: QR189.2

Dewey Class. No.: 615.372

mRNA vaccines
LDR:03257nmm a2200337 a 4500 001 2306734
003 DE-He213
005 20230103132023.0
006 m d
007 cr nn 008maaau
008 230421s2022 sz s 0 eng d
020 $a 9783031180705 $q (electronic bk.)
020 $a 9783031180699 $q (paper)
024 7 $a 10.1007/978-3-031-18070-5 $2 doi
035 $a 978-3-031-18070-5
040 $a GP $c GP
041 0 $a eng
050 4 $a QR189.2
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
072 7 $a MJCM $2 thema
082 0 4 $a 615.372 $2 23
090 $a QR189.2 $b .M939 2022
245 0 0 $a mRNA vaccines $h [electronic resource] / $c edited by Dong Yu, Benjamin Petsch.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a xi, 205 p. : $b ill. (chiefly color), digital ; $c 24 cm.
490 1 $a Current topics in microbiology and immunology, $x 2196-9965 ; $v v. 437
505 0 $a Preface -- mRNA-based vaccines and mode of action -- Self-Amplifying mRNA-Based Vaccine Technology and its Mode of Action -- Formulation and Delivery Technologies for mRNA Vaccines -- Messenger RNA-based vaccines against infectious diseases -- Emerge gate for Therapeutics applications of mRNA based drug -- Clinical Development of mRNA Vaccines: Challenges and Opportunities -- Regulatory Considerations on the Development of mRNA Vaccines.
520 $a The formulation and the technological advancements in RNA biology, chemistry, stability, and encapsulated delivery systems that have enabled the development of fully synthetic mRNA vaccines are discussed in this volume. The applications of the mRNA technology is covered, focusing on infectious diseases but also touching on other indications, such as immunotherapies and molecular therapies. Potent and long-lasting immune responses observed in animal models, encouraging data from early human clinical studies, together with the success of two mRNA-based COVID-19 vaccines support the use of mRNA-based vaccination as an attractive alternative to conventional vaccine approaches. Consequently, the development progress of the technology, particularly on production, capabilities, and clinical development is reviewed. Topics on safety, regulatory issues, and possible challenges to the mRNA vaccination approach round off this book. Thanks to their high potency, the prospect for generic, low-cost manufacturing processes, and entirely synthetic nature, the future for mRNA vaccines is highly promising. Importantly, mRNA vaccines have the potential to minimize the time between pathogen identification and vaccine release with a huge impact on public health. As the mRNA-based vaccination technology has been progressing rapidly, the book is intended to be an end-to-end review series, covering everything from basic RNA biology and preclinical studies to the manufacturing strategy, clinical development and regulatory approval. It provides established RNA researchers and developers with updates on the latest advancements in the field and allows for a quick but comprehensive overview of this transformative technology, its application, and future potential.
650 0 $a mRNA vaccines. $3 3605295
700 1 $a Yu, Dong. $3 2131828
700 1 $a Petsch, Benjamin. $3 3611215
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Current topics in microbiology and immunology ; $v v. 437. $3 3611216
856 4 0 $u https://doi.org/10.1007/978-3-031-18070-5
950 $a Biomedical and Life Sciences (SpringerNature-11642)